Strong Diagnostic Performance of Single Energy 256-row Multidetector Computed Tomography with Deep Learning Image Reconstruction in the Assessment of Myocardial Fibrosis.

Journal: Internal medicine (Tokyo, Japan)
PMID:

Abstract

Objective Although magnetic resonance imaging (MRI) is the gold standard for evaluating abnormal myocardial fibrosis and extracellular volume (ECV) of the left ventricular myocardium (LVM), a similar evaluation has recently become possible using computed tomography (CT). In this study, we investigated the diagnostic accuracy of a new 256-row multidetector CT with a low tube-voltage single energy scan and deep-learning-image reconstruction (DLIR) in detecting abnormal late enhancement (LE) in LVM. Methods We evaluated the diagnostic performance of CT for detecting LE in LVM and compared the results with those of MRI as a reference. We also measured the ECV of the LVM on CT and compared the results with those on MRI. Materials We analyzed 50 consecutive patients who underwent cardiac CT, including a late-phase scan and MRI, within three months of suspected cardiomyopathy. All patients underwent 256-slice CT (Revolution APEX; GE Healthcare, Waukesha, USA) with a low tube-voltage (70 kV) single energy scan and DLIR for a late-phase scan. Results In patient- and segment-based analyses, the sensitivity, specificity, and accuracy of detection of LE on CT were 94% and 85%, 100% and 95%, and 96% and 93%, respectively. The ECV of LVM per patient on CT and MRI was 33.0±6.2% and 35.9±6.1%, respectively. These findings were extremely strongly correlated, with a correlation coefficient of 0.87 (p<0.0001). The effective radiation dose on late-phase scanning was 2.4±0.9 mSv. Conclusion The diagnostic performance of 256-row multislice CT with a low tube voltage and DLIR for detecting LE and measuring ECV in LVM is credible.

Authors

  • Shuhei Aoki
    Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Japan.
  • Hiroyuki Takaoka
    Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, Japan. tapy21century@yahoo.co.jp.
  • Joji Ota
    Department of Radiology, Chiba University Hospital, Chiba, Japan.
  • Tomonori Kanaeda
    Department of Cardiology, Eastern Chiba Medical Center, Togane, Japan.
  • Takayuki Sakai
    Department of Radiology, Eastern Chiba Medical Center, Japan.
  • Koji Matsumoto
    Japan Automobile Research Institute.
  • Yoshitada Noguchi
    Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Japan.
  • Yusei Nishikawa
    Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Japan.
  • Satomi Yashima
    Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Japan.
  • Katsuya Suzuki
    Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Kazuki Yoshida
    Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Makiko Kinoshita
    Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Japan.
  • Noriko Suzuki-Eguchi
    Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Japan.
  • Haruka Sasaki
    Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Japan.
  • Yoshio Kobayashi
    Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Chiba, Japan.